摘要
本文采用放免测定法研究了生长抑素（ｓｏｍａｔｏｓｔａｔｉｎ，ｓｓ）在胃及食管癌患者血浆与癌组织中的变化。结果表明：食管癌和胃癌患者血浆和癌组织中ｓｓ的含量（食管癌：１７．８７±５．３１ｐｇ／ｍｌ，４０．４１±１３．２６ｐｇ／ｍｇ；胃癌：１１．２４±５．１１ｐｇ／ｍｌ，１３０．１８±３７．７３ｐｇ／ｍｇ）显著低于正常人（２６．８３±５．９２，２１２．６２±４７．４６ｐｇ／ｍｇ）Ｐ＜０．０１，提示：ｓｓ的减少可能与上消化道癌肿形成有关。
The contents of somatostatin in plasma and tumor tissue in patients with esophageeal cancer and gastric cancer. The resuts showed that the contents of somatostatin in plasma and tumor tissue in patients with esophageal cancer(17.87±5.31 pg/ml, 44.41 ± 13.26pg/mg)and gastric cancer(11.24 ± 5.11pg/mg,130.18±37.73pg/mg)were significantly lower than in normal subjects (26. 83 ± 5.92/mg,212.62 ±47.46pg/mg) (P<0.01 ).These results suggest that somatostatin is related to gastrentestinal tract cancer.
出处
《胃肠病学和肝病学杂志》
CAS
1996年第4期251-253,共3页
Chinese Journal of Gastroenterology and Hepatology
关键词
生长抑素
食管肿瘤
胃肿瘤
癌
Somatostatin
Gastric cancer
Esophageal cancer .
